© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Latebreakers: Transdermal option given OK for Parkinson's disease
A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).